Zomedica Puts Veterinarians First at 2018 Veterinary Innovation Summit

Zomedica

April 16, 2018 Last week, Zomedica’s Chief Operations Officer and Vice President of Product Development, Stephanie Morley, DVM, was honored to present at the 2018 Veterinary Innovation Summit on the criticality of Voice of Customer in all stages of the innovation lifecycle. Hosted by the NAVC, Texas A&M College of Veterinary Medicine and the Veterinary Innovation Council, the Veterinary Innovation …

Zomedica discusses the need for pet cancer diagnostics in the latest Investor Chat podcast from Stockhouse

Zomedica

March 19, 2018 In many respects, animal health is an under-served field. Many of the medications used to treat animal health disorders are actually human drugs, developed for human physiology, and compounded drugs that have not been proven safe or effective for animal use. As Zomedica began advancing its pipeline of pet pharmaceutical products, the company’s attention was drawn to …

Winners of Zomedica-Sponsored Veterinary Innovation Awards Announced by NAVC and The Veterinary Innovation Council

Zomedica

February 4, 2018 The North American Veterinary Community (NAVC) and the Veterinary Innovation Council (VIC) are excited to announce the winners of their first ever Veterinary Innovation Awards. Sponsored by Zomedica (NYSE American:ZOM) (TSX-V:ZOM), these awards showcase the passionate innovators and organizations that have dedicated themselves to the betterment of the animal health industry. LEARN MORE>>  

Zomedica Pharmaceuticals Corp. Enters into License and Supply Agreement with Celsee, Inc. for Cancer Liquid Biopsy Platform

Zomedica

ANN ARBOR, Mich., Dec. 21, 2017 (GLOBE NEWSWIRE) – Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and diagnostic company, today announced it has entered into a license and supply agreement with Celsee, Inc. (“Celsee”), an innovator of progressive rare cell capture, characterization and retrieval products in the emerging field of liquid biopsy. Under the terms …